Подписаться на новости
  • Сенатор
  • ООО "Ай Вао"
  • Биомолтекст2020
  • vsh25
  • Vitacoin

Список литературы к статье «Геропротекторы: самая полная база данных»

  1. Correia-MeloC and PassosJF.Mitochondria: Are they causal players in cellular senescence? Biochim Biophys Acta. 2015 
  2. RieraCEand DillinA. Tipping the metabolic scales towards increased longevity in mammals. Nat. Cell. Biol.2015; 17:196-203. 
  3. Zhavoronkov A and Cantor CR. Methods for Structuring Scientific Knowledge from Many Areas Related to Aging Research. PloS one. 2011; 6.7:e22597. 
  4. Moskalev AA, Aliper AM, Smit-McBride Z, Buzdin A, Zhavoronkov A. Genetics and Epigenetics of Aging and Longevity. Cell Cycle. 2014; 13.7:1063-1077. 
  5. ShresthaLB, and HeislerEJ. The changing demographic profile of the United States. CRS Report. 2011; 7-5700. 
  6. HalaweishI, and AlamHB. Changing demographics of the American population. Surg. Clin. North. Am.2015; 95:1-10. 
  7. Zhavoronkov A, and Litovchenko M. Biomedical Progress Rates as New Parameters for Models of Economic Growth in Developed Countries. International journal of environmental research and public health. 2013; 10.11: 5936-5952. 
  8. SloanePD, ZimmermanS, SuchindranC, ReedP, WangL, BoustaniM,and SudhaS. The public impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances. Annu. Rev. Public Health. 2002; 23:213-231. 
  9. SpillmanBC,and LubitzJ. The effect of longevity on spending for acute and long-term care. N. Engl. J. Med. 2000; 342:1409-1415. 
  10. BlagosklonnyMV. Validation of anti-aging drugs by treating age-related diseases. Aging (Albany NY). 2009; 1:281-288. 
  11. BlagosklonnyMV. Koschei the immortal and anti-aging drugs. Cell Death Dis. 2014; 5:e1552-e1557. 
  12. SchlickerC, BoancaG, LakshminarasimhanM, and SteegbornC. Structure-based development of novel sirtuin inhibitors. Aging (Albany NY). 2011; 3:852-872. 
  13. MarilenaG. Can ageing be slowed? Hormetic and redox perspectives. J. Med. Life. 2011; 4:346-351. 
  14. KasiotisKM, PratsinisH, KletsasD, and HaroutounianSA.Resveratrol and related stilbenes: Their anti-aging and anti-angiogenic properties. Food Chem. Toxicol. 2013; 61:112-120. 
  15. ErginV, HariryRE, and KarasuC. Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators. Aging Dis. 2013; 4:276-94. 
  16. ZhavoronkovA, BuzdinAA, GarazhaAV, BorisovNM, and MoskalevAA. Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs. Front. Genetics. 2014; 5:49. 
  17. Makarev E, Cantor C, Zhavoronkov A, Buzdin A, Aliper A, and Csoka AB. Pathway Activation Profiling Reveals New Insights into Age-Related Macular Degeneration and Provides Avenues for Therapeutic Interventions. Aging (Albany NY). 2014; 6.12:1064. 
  18. Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, and Zhavoronkov A.Signaling Pathway Activation Drift during Aging: Hutchinson-Gilford Progeria Syndrome Fibroblasts Are Comparable to Normal Middle-Age and Old-Age Cells. Aging (Albany NY). 2015; 7:26-37. 
  19. Blagosklonny MV. Prevention of cancer by inhibiting aging. Cancer Biology & Therapy. 2008; 7:1520-1524. 
  20. Blagosklonny MV. Increasing healthy lifespan by suppressing aging in our lifetime: preliminary proposal. Cell Cycle. 2010; 9:4788-4794. 
  21. Blagosklonny MV. Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration. Cell Cycle. 2009; 8:1883-1887. 
  22. Blagosklonny MV. Validation of anti-aging drugs by treating age-related diseases. Aging. 2009; 1:281. 
  23. Blagosklonny MV. Prospective treatment of age-related diseases by slowing down aging. The American journal of pathology. 2012; 181:1142-1146. 
  24. Blasera MJ, and Webb GF. Host demise as a beneficial function of indigenous microbiota in human hosts. mBio. 2014; 5:e02262-14. 
  25. Baker GT,3rd, and Sprott RL. Biomarkers of aging. Exp Gerontol. 1988; 23:223-239. 
  26. Simm A, Nass N, Bartling B, Hofmann B, Silber RE, Navarrete Santos A. Potential biomarkers of ageing. Biol Chem. 2008; 389:257-265. 
  27. Johnson TE. Recent results: biomarkers of aging. Exp. Gerontol. 2006; 41:1243-1246. 
  28. Wang Y, Xiao J, Pan RL, Liu XM, Liao YH, Feng L, Cao FR, and Chang Q. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 2009; 37:W623-W633. 
  29. Wang Y, Suzek T, Zhang J, Wang J, He S, Cheng T, Shoemaker BA, Gindulyte A, Bryant SH. PubChem BioAssay: 2014 update. Nucleic Acids Res. 2014; 42:D1075-D1082. 
  30. Brooksbank C, Cameron G, Thornton J. The European Bioinformatics Institute's data resources: towards systems biology. Nucleic Acids Res. 2005; 33:D46-D53. 
  31. Degtyarenko K, de Matos P, Ennis M, Hastings J, Zbinden M, McNaught A, Alcántara R, Darsow M, Guedj M, Ashburner M. ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2008; 36: D344-D350. 
  32. Hastings J, de Matos P, Dekker A, Ennis M, Harsha B, Kale N, Muthukrishnan V, Owen G, Turner S, Williams M, Steinbeck C.The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Res. 2013; 41:D456-D463. 
  33. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, et al. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res. 2012; 40:D1100-1107. 
  34. Willighagen EL, Waagmeester A, Spjuth O, Ansell P, Williams AJ, Tkachenko V, Hastings J, Chen B, Wild DJ. The ChEMBL database as linked open data. J. Cheminform. 2013; 5:23. 
  35. Davies M, Nowotka M, Papdatos G, Dedman N, Gaulton A, Atkinson,F, Bellis L, and Overington JP. ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res. 2015; gkv352. 
  36. Williams A. ChemSpider and its expanding web: Building a structure-centric community for chemists. Chem. International. 2008; 30:1. 
  37. Pence HE, and Williams A. ChemSpider: A Hub for Online Chemical Information Resources. J. Chem. Education. 2010; 87:1123-1124. 
  38. Williams AJ, Tkachenko V, Golotvin S, Kidd R, and McCann G. ChemSpider - building a foundation for the semantic web by hosting a crowd sourced databasing platform for chemistry. J Cheminform . 2010; 2:016. 
  39. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, and Woolsey J. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006; 34:D668-D672. 
  40. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, and Hassanali M. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008; 36:D901-D906. 
  41. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V. et al. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011; 39:D1035-D1041. 
  42. Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A., Arndt,D, Wilson M, Neveu V, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014; 42:D1091-D1097. 
  43. Hewett M, Oliver DE, Rubin DL, Easton KL, Stuart JM, Altman RB, Klein TE. PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res. 2002; 30:163-165. 
  44. Kuhn M, Campillos M, Letunic I, Jensen LJ, and Bork P. A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol. 2010; 6:343. 
  45. Chen X, Ji ZL, and Chen YZ. TTD: Therapeutic Target Database. Nucleic Acids Res. 2002; 30:412-415. 
  46. Qin C, Zhang C, Zhu F, Xu F, Chen SY, Zhang P, Hong Y, Yang SY, Wei YQ, and Tao L. Therapeutic target database update 2014: a resource for targeted therapeutics. Nucleic Acids Res. 2014; 42:D1118-D1123. 
  47. Kanehisa M, Goto S, Kawashima S, Okuno Y, and Masahiro H. The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004; 32:D277-D280. 
  48. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S. et al. HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007; 35:D521-D526. 
  49. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E. et al. HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res. 2013; 41:D801-D807. 
  50. Wexler P. TOXNET: an evolving web resource for toxicology and environmental health information. Toxicology. 2001; 157:3-10. 
  51. Hoofnagle JH, Serrano J, Knoben JE, and Navarro VJ. LiverTox: a website on drug-induced liver injury. Hepatology. 2013; 57:873-874. 
  52. Edgar R, Domrachev M, and Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002; 30:207-210 
  53. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM. et al. NCBI GEO: archive for functional genomics data sets--10 years on. Nucleic Acids Res. 2011; 39:D1005-D1010. 
  54. Duan Q, Flynn C, Niepel M, Hafner M, Muhlich JL, Fernandez NF, Rouillard AD, Tan CM, Chen EY, Golub T. et al. LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures. Nucleic Acids Res. 2014; 42:W449-W460. 
  55. Consortium U.C.P.M.C. The Universal Protein Resource (UniProt). Nucleic Acids Res. 2007; 35:D193-D197. 
  56. Zarin DA, Tse T, Williams RJ, Califf RM, and Ide NC. The ClinicalTrials.gov results database--update and key issues. N. Engl. J. Med. 2011; 364:852-860. 
  57. Williams RJ, and Tse T. New Look for ClinicalTrials.gov. NLM Tech Bull. 2007; 358:e2. 
  58. Hühne R, Thalheim T, and Sühnel J. AgeFactDB - The JenAge Ageing Factor Database - Towards data integration in ageing research. Nucleic Acids Res. 2014; 42:892-896. 
  59. Tacutu R, Craig T, Budovsky A, Wuttke D, Lehmann G, Taranukha D, Costa J, Fraifeld VE, and de Magalhaes JP. Human Ageing Genomic Resources: integrated databases and tools for the biology and genetics of ageing. Nucleic Acids Res. 2013; 41: D1027-1033. 
  60. Wen H, Gao X, and Qin J. Probing the anti-aging role of polydatin in Caenorhabditis elegans on a chip. Integr. Biol. 2014; 6:35-43. 
  61. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang L-L, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425:191-196. 
  62. Viswanathan M, Kim SK, Berdichevsky A, and Guarente L. A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell. 2005; 9:605-615. 
  63. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, and Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004; 430:686-689. 
  64. Bauer JH, Goupil S, Garber GB, and Helfand SL. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc. Natl. Acad. Sci. U. S. A. 2004; 101:12980-12985. 
  65. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, and Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 2006; 16:296-300. 
  66. Wen H, Gao X, and Qin,J. Probing the anti-aging role of polydatin in Caenorhabditis elegans on a chip. Integr. Biol. (Camb). 2014; 6:35-43.
Портал «Вечная молодость» http://vechnayamolodost.ru
30.09.2015
Версия для печати
Ошибка в тексте?
Выдели ее и нажми ctrl + enter
назад